No new cardiovascular warnings needed for NSAIDs say FDA advisers

SILVER SPRING, MD. – There do not need to be major changes to the warning labels on prescription and over-the-counter nonsteroidal anti-inflammatory medications, said a group of federal advisers on...

Field of Interest: Rheumatology